Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 2
2012 3
2013 3
2014 2
2015 1
2017 1
2018 2
2019 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Results by year
Filters applied: . Clear all
Page 1
Identification of adenine-N9-(methoxy)ethyl-β-bisphosphonate as NPP1 inhibitor attenuates NPPase activity in human osteoarthritic chondrocytes.
Nassir M, Arad U, Lee SY, Journo S, Mirza S, Renn C, Zimmermann H, Pelletier J, Sévigny J, Müller CE, Fischer B. Nassir M, et al. Purinergic Signal. 2019 Jun;15(2):247-263. doi: 10.1007/s11302-019-09649-2. Epub 2019 Apr 25. Purinergic Signal. 2019. PMID: 31025169 Free PMC article.
Structure-Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5'-Nucleotidase (CD73) Inhibitors.
Junker A, Renn C, Dobelmann C, Namasivayam V, Jain S, Losenkova K, Irjala H, Duca S, Balasubramanian R, Chakraborty S, Börgel F, Zimmermann H, Yegutkin GG, Müller CE, Jacobson KA. Junker A, et al. J Med Chem. 2019 Apr 11;62(7):3677-3695. doi: 10.1021/acs.jmedchem.9b00164. Epub 2019 Mar 21. J Med Chem. 2019. PMID: 30895781
A unique amidoanthraquinone derivative displays antiproliferative activity against human hormone-refractory metastatic prostate cancers through activation of LKB1-AMPK-mTOR signaling pathway.
Hsu JL, Liu SP, Lee CC, Hsu LC, Ho YF, Huang HS, Guh JH. Hsu JL, et al. Naunyn Schmiedebergs Arch Pharmacol. 2014 Oct;387(10):979-90. doi: 10.1007/s00210-014-0998-9. Epub 2014 Jul 9. Naunyn Schmiedebergs Arch Pharmacol. 2014. PMID: 25005758
Purinergic signalling: from discovery to current developments.
Burnstock G. Burnstock G. Exp Physiol. 2014 Jan;99(1):16-34. doi: 10.1113/expphysiol.2013.071951. Epub 2013 Sep 27. Exp Physiol. 2014. PMID: 24078669 Free PMC article. Review.
16 results
Jump to page